13D Filing: Baker Bros. Advisors and Acadia Pharmaceuticals Inc (NASDAQ:ACAD)

Published on September 24, 2018 at 10:50 am by Insider Monkey Staff in Hedge Funds, Insider Trading, News

<< Prev

Page 3 of 10

Next >>

See All

Page 3 of 10 – SEC Filing

CUSIP No. 004225108

Page 3 of 10 Pages

1.	NAMES OF REPORTING PERSONS Baker Bros. Advisors (GP) LLC
2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) ¨ (b) ¨
3.	SEC USE ONLY
4.	SOURCE OF FUNDS* OO
5.	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) o
6.	CITIZENSHIP OR PLACE OF ORGANIZATION Delaware

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	7.	SOLE VOTING POWER: 28,570,614 (1)
	8.	SHARED VOTING POWER: 0
	9.	SOLE DISPOSITIVE POWER: 28,570,614 (1)
	10.	SHARED DISPOSITIVE POWER: 0

11.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON: 28,570,614 (1)
12.	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* ¨
13.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 22.8% (1)(2)
14.	TYPE OF REPORTING PERSON* HC, OO

(1)

Includes 46,250 shares of the common stock of the Issuer underlying options directly held by Julian C.
Baker, a Managing Member of the Adviser GP and 85,250 shares of the common stock of the Issuer underlying options directly held
by Dr. Stephen R. Biggar, a full-time employee of the Adviser.

(2)

Based on 125,006,723 shares of the Issuer’s common
stock outstanding as of July 31, 2018, as reported in the Issuer’s Form 10-Q filed with the SEC on August 8, 2018.